27 August 2013
Biofortuna raises £1.3m of investment for growth in its freeze-dried molecular diagnostics business and service provision
Portfolio company Biofortuna, a UK based molecular diagnostics company with a proprietary stabilisation technology for molecular reagents, is expanding its custom service and manufacturing business with a £1.3m investment. The new funds will enable the business to expand...
6 August 2013
Crystallon instals 2000th Cryostream
Catapult would like to congratulate its portfolio company Crystallon, which trades as Oxford Cryosystems, on installing the 2000th Cryostream since the business was started. Thirty years ago two scientists working in a lab at Oxford University came up with a ground-breaking...
1 August 2013
PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals
PolyTherics Limited (“PolyTherics”) announces that it has merged with Antitope Limited (“Antitope”), the leading provider of antibody engineering and immunogenicity screening services, to create an enlarged group with an extensive suite of services and...
30 July 2013
Sky will use a joint NICE-Silver Lining workforce optimisation solution to more effectively manage its multi-site, multi-skill, contact centre environment.
Silver Lining Solutions today announced that it has been selected by Sky (BSkyB) to help enhance customer experience and improve operational efficiency. Sky will utilise a joint NICE-Silver Lining workforce optimisation (WFO) solution to more effectively manage its multi-skilled...
25 July 2013
Lumora Signs Supply Agreement with Promega for Ultra-Glo Luciferase, to be used in Lumora’s BART Molecular Diagnostics Technology
Portfolio company Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, and Promega, a leader in providing innovative solutions and technical support to the life sciences industry, have signed a supply agreement for the use...
22 July 2013
Sight and Sound celebrate winning the Midlands Venture Capital backed team of the year award at the gala dinner
Sight and Sound Technology was delighted to receive their BVCA Award for the ‘Venture Capital Backed Management Team of the Year’. The award was accepted after a wonderful evening at the award ceremony in Marriot Grosvenor Square Hotel in London on July 4th 2013.
1 July 2013
Oxford BioTherapeutics Appoints Bryan G. Morton as Chairman
Portfolio company Oxford BioTherapeutics (OBT), a global biotechnology company developing first-in-class, antibody-based cancer medicines to fulfil unmet patient needs, today announces the appointment of Bryan G. Morton as the Company’s new Non-executive Chairman. Bryan...
27 June 2013
Monica Healthcare developing new generation products
Monica Healthcare Ltd, the Nottingham developers of a new breed of fetal monitoring equipment, has secured a further cash injection from investors to commence the development of its ‘next’ generation products. This funding round for the Biocity-based company has been...
12 June 2013
Michelson Diagnostics wins Regulatory Approval for VivoSight OCT Scanner in Australia
Portfolio company Michelson Diagnostics, the UK based medical device company, has been given regulatory approval by the Therapeutics Goods Administration (TGA) in Australia to start selling its market leading VivoSight OCT Scanner. Australia has the highest incidence of skin...
5 June 2013
Lumora agrees licence and development program for Veterinary applications with Biogal Galed Labs
Portfolio company Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has entered into a license and development agreement with Biogal Galed Labs ACS Ltd, a provider of veterinary diagnostics, to develop a series of...